期刊
PROSTATE CANCER AND PROSTATIC DISEASES
卷 11, 期 3, 页码 216-229出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/pcan.2008.2
关键词
serum; biomarkers; CgA; hK2; AMACR autoantibodies; GSTP1 hypermethylation
There is a need to improve existing methods for early diagnosis of prostate cancer (CaP) and to identify men at risk for developing aggressive disease. In an effort to replace and/or supplement prostate-specific antigen many serum analytes have been examined, but with little supportive data for clinical use. Recently, technological advances in molecular assays have improved investigational outcomes and have led to the discovery of a number of prospective markers with high specificity. Further promise for providing more accurate CaP diagnosis and prognosis lies in proteomic array profiling and DNA methylation assays. This review illustrates the current benefits and limitations of potentially useful CaP serum markers that have considerable existing data and touches upon other future markers as well as the field of proteomics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据